Intravenous sildenafil as an effective treatment of pulmonary hypertensive crises during acute intestinal malabsorption
- 1 January 2006
- journal article
- case report
- Published by Cambridge University Press (CUP) in Cardiology in the Young
- Vol. 16 (1), 84-86
- https://doi.org/10.1017/s1047951105002155
Abstract
Oral sildenafil has been demonstrated to be an effective treatment for pulmonary hypertension, and is increasingly used in children. We report an infant with pulmonary hypertension, stable on regular treatment with oral sildenafil, who presented in acute respiratory failure after aspiration, requiring ventilation and intensive care. The course of the stay in intensive care was difficult, with recurrent pulmonary hypertensive crises despite use of oral sildenafil, use of 100% oxygen, high frequency oscillatory ventilation, and inhaled nitric oxide. In view of his instability, and the presumed inability to absorb the sildenafil orally due to gastrointestinal malabsorption, sildenafil was administered as a continuous intravenous infusion. With this therapy, it proved possible to wean from oxygen, nitric oxide, and ventilatory support. Intravenous sildenafil, therefore, might be an effective alternative for children with pulmonary hypertension during episodes of acute deterioration and malabsorption, preventing life-threatening pulmonary hypertensive crises. Its pharmacokinetics, efficacy, and safety, nonetheless, need to be validated in randomized controlled trials.Keywords
This publication has 9 references indexed in Scilit:
- Clinical efficacy of sildenafil in primary pulmonary hypertensionJournal of the American College of Cardiology, 2004
- Hemodynamic Response to Sildenafil, Nitric Oxide, and Iloprost in Primary Pulmonary HypertensionChest, 2004
- Intravenous sildenafil and inhaled nitric oxide: a randomised trial in infants after cardiac surgeryIntensive Care Medicine, 2003
- Intravenous Sildenafil Is a Potent Pulmonary Vasodilator in Children With Congenital Heart DiseaseCirculation, 2003
- Long-term Treatment With Oral Sildenafil in Addition to Continuous IV Epoprostenol in Patients With Pulmonary Arterial HypertensionChest, 2003
- Sildenafil for treatment of lung fibrosis and pulmonary hypertension: a randomised controlled trialThe Lancet, 2002
- Intravenous Sildenafil Lowers Pulmonary Vascular Resistance in a Model of Neonatal Pulmonary HypertensionAmerican Journal of Respiratory and Critical Care Medicine, 2002
- Sildenafil in Primary Pulmonary HypertensionNew England Journal of Medicine, 2000
- Sildenafil as a selective pulmonary vasodilator in childhood primary pulmonary hypertensionHeart, 2000